Skip to main content

Day: April 2, 2025

NANO Nuclear and University of Illinois Urbana-Champaign Sign Landmark Agreement to Build the First KRONOS MMR™ Research Reactor

NANO Nuclear Energy Inc.Rendering of NANO Nuclear’s KRONOS MMR™ Energy System at the University of IllinoisSite Selected and Preparatory Work to Begin for Construction Permit Application as NANO Nuclear Accelerates Toward Microreactor Deployment NEW YORK, NY, April 02, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, is pleased to announce the signing of a strategic collaboration with the University of Illinois Urbana-Champaign (U. of I.) to construct the first research KRONOS micro modular reactor (MMR) on the university’s campus. The agreement formally establishes U. of I. as a partner in the licensing, siting, public engagement, and research operation of the...

Continue reading

HII is Awarded Air National Guard Training Contract to Enhance Readiness

MCLEAN, Va., April 02, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Mission Technologies division was awarded a $133 million contract by the U.S. Air National Guard to enhance the readiness and proficiency of flying units through live, virtual and constructive training. Under the 10-year task order, HII will provide expertise and staffing for the execution of distributed mission operations (DMO) events at the U.S. Air National Guard’s Distributed Training Operations Center (DTOC). Located on the Des Moines Air National Guard base, the DTOC is housed in the 132d Combat Training Squadron and connects more than 90 simulation sites across the country servicing readiness via training for the total and joint forces. “Incorporating live, virtual, constructive elements into training dramatically increases the level...

Continue reading

VivoPower Provides Update on Non-Binding Takeover Offer at Enterprise Value of US$180 Million and Tembo Business Combination Agreement at Combined Enterprise Value of US$904 Million

LONDON, April 02, 2025 (GLOBE NEWSWIRE) — VivoPower International PLC (Nasdaq: VVPR) (“VivoPower” or the “Company”) hereby provides an update on the non-binding takeover offer from Energi Holdings Limited (“Energi”) to acquire the non-affiliated shareholders of VivoPower at an enterprise valuation of US$180 million and the Tembo business combination agreement with Cactus Acquisition Corporation 1 Limited (“CCTS”) at a combined enterprise valuation of US$904 million, assuming no public trust redemptions for CCTS. As announced on 26 March 2025, VivoPower’s board was targeting the completion of negotiations on price, terms and conditions with Energi by 2 April 2025. This has been achieved with an increase in the original takeover enterprise value of US$120million to US$180million subject to a due diligence...

Continue reading

Resolution on completion of share split in ROCKWOOL A/S in the ratio of 1:10

Company announcementfor ROCKWOOL A/SRelease no. 19 – 2025to Nasdaq Copenhagen         2 April 2025 Resolution on completion of share split in ROCKWOOL A/S in the ratio of 1:10 At the annual general meeting of ROCKWOOL A/S (the “Company“) held today, it was resolved to implement a share split of the Company’s shares in the ratio of 1:10. As a result of the share split, each existing class A and B share with a nominal value of 10 DKK will be split into 10 shares with a nominal value of 1 DKK. Following the share split:The Company’s A share capital of nominally 98,178,390 DKK will comprise 98,178,390 A shares of 1 DKK each, each carrying 10 votes. The Company’s B share capital of nominally 118,028,700 DKK will comprise 118,028,700 B shares of 1 DKK each, each carrying one vote.After completion of the share split, the Company’s...

Continue reading

In challenging market conditions, SYNERGIE continues to grow while preserving its financial robustness

Paris, April 2nd, 2025 IN CHALLENGING MARKET CONDITIONS, SYNERGIE CONTINUES TO GROW WHILE PRESERVING ITS FINANCIAL ROBUSTNESS Revenue: €3,184.9 million EBITDA: €130.6 million Net profit: €67.1 million On April 2nd, 2025, 2024 SYNERGIE Board of Directors, chaired by Mr Victorien Vaney,approved the consolidated full year financial statements for the period ended December 31st , 2024. The auditing procedures for these financial statements are complete and the corresponding reports are being issued.Consolidated – in € million 2024 2023 Variation %Revenue 3,184.9 3,108.5 +2.5%EBITDA 130.6 153.2 -14.8%EBITA* 103.7 127.9 -18.9%Operating profit 95.6 116.1 -17.7%Net profit 67.1 78.6 -14.6%Net profit Group share 63.1 74.9 -19,7%* Current operating profit before amortisation and impairment of intangible assets REVENUE...

Continue reading

EssilorLuxottica: EssilorLuxottica’s employee shareholding plans reach record investment, reflecting strong confidence in the Group’s strategy

EssilorLuxottica’s employee shareholding plans reach record investment, reflecting strong confidence in the Group’s strategy Today, the Group totals almost 100,000 internal shareholders in 85 countries Paris, France (2 April 2025) – EssilorLuxottica continues to grow and create value for shareholders. Following record-breaking investments in the SuperBoost 2025 international shareholding plan and the French PEE in 2024, internal shareholders now total 97,000 across 85 countries, up from 83,500 in 2024. In 2025, EssilorLuxottica introduced an enhanced version of its traditional program with three new investment options, expanding beyond traditional choices and matching conditions to encourage even greater participation and foster deeper employee engagement in the Company’s growth. The subscription plan raised over Euro 190 million, more...

Continue reading

Arcutis and Padagis Agree to Stay Patent Lawsuit

WESTLAKE VILLAGE, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, is pleased to announce that Padagis Israel Pharmaceuticals Ltd., Padagis US LLC, and Padagis LLC (Padagis) have requested a stay to the ongoing patent litigation between Padagis and the Company, and the Company has agreed to enter a joint stipulation to stay the case, which was filed in the U.S. District Court for the District of Delaware on April 2, 2025. After the Court enters the joint stipulation, all calendared dates and trial for the patent litigation will be vacated. As part of the joint stipulation agreement, Padagis is required to report to Arcutis any U.S. Food and Drug Administration (FDA) correspondence...

Continue reading

ISC Responds to Tender Offer by Plantro Ltd.

REGINA, Saskatchewan, April 02, 2025 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISC) (“ISC” or the “Company”) confirms that the Board of Directors (the “Board”) of the Company is aware of the news release issued this morning related to a tender offer by Plantro Ltd. to acquire up to 15% of Class A Limited Voting Shares of ISC. The Board was first contacted by Plantro Ltd. in relation to this matter on March 31, 2025 and is reviewing and will assess this offer on its merits. The Company has a long and proven track record of success. It remains focussed on executing on its 2028 goal to double the size of the Company on a revenue and adjusted EBITDA basis, based on its actual 2023 revenue and adjusted EBITDA, and maximizing shareholder value. About ISC®Headquartered in Canada, ISC is a leading provider of registry and...

Continue reading

Minutes of Annual General Meeting 2025

Company announcementfor ROCKWOOL A/SRelease no. 18 – 2025to Nasdaq Copenhagen         2 April 2025 Minutes of Annual General Meeting 2025 The annual general meeting of ROCKWOOL A/S was held on 2 April 2025 at 3:00 p.m. at Roskilde Kongrescenter, Denmark. At the general meeting, the board of directors’ report for the financial year of 2024 was noted, the annual report for 2024 was approved and the management and the board of directors were discharged from liability. Furthermore, the remuneration report for 2024 was approved. The general meeting approved the remuneration of the board of directors, including the remuneration of members of the Audit Committee and the Remuneration and Nomination Committee, respectively, for the period from the annual general meeting in 2025 to the annual general meeting in 2026. The general meeting approved...

Continue reading

Scatec ASA: Mandatory notifications of trade by primary insiders

Oslo, 2 April 2025: Two board members have today bought shares in Scatec ASA. Mette Krogsrud, board member of Scatec ASA, has on 2 April bought 3,000 shares in Scatec ASA at an average price per share of 77.00. After the transaction Mette Krogsrud owns 6,000 shares in Scatec ASA. Ketal AS, a company controlled by Maria Tallaksen, board member of Scatec ASA, has on 2 April bought 1,300 shares in Scatec ASA at an average price per share of NOK 77.54. After the transaction Ketal AS owns 1,300 shares in Scatec ASA. Attached is the notification of the transaction in accordance with the Market Abuse Regulation Article 19. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading act.Attachments250402 – Notification...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.